TOKYO -- In spring 2020, as the COVID-19 pandemic took hold, many pharmaceutical companies faced supply chain disruptions. Often, chemicals used to produce the key ingredients in drugs were sourced from only a few suppliers in China -- or sometimes just one.
The pandemic has brought to light just how much the global pharmaceutical supply chain depends on China, even for the most basic ingredients.
